Equalizing access to innovative treatments across MERAT
About Us
Since 2013, Inpharmus is the leading commercialization partner connecting innovator biopharma with the Middle East, Russia&CIS, North Africa, Türkiye Region- an overlooked and high-potential market that covers 350 million people.
We accelerate patient access to life-changing oncology, hematology and rare disease treatments, address a fundamental market gap by connecting innovation with patients in need, and make our Region more accessible, more navigable, and better served.
We provide to our partners a reliable, evidencedriven expertise across all stakeholders, ensuring that Our Partners’ products are managed with the highest standards of safety, compliance, and operational precision.
Rare Diseases
Diseases that affect a small percentage of people compared to the general population are known as rare diseases. Specific problems arise in these disorders due to their rare occurrence. While a disease can be rare in one region, it may be common in another.
To date, more than 7,000 rare diseases have been identified, and this number continues to grow.
Hematology
The hematologic system plays a vital role in oxygen transport, immune defense, coagulation and cellular homeostasis. Disorders affecting this system may arise from defects in blood cell production, proliferation, differentiation or immune regulation. The clinical spectrum ranges from acquired conditions to genetically driven immune dysregulation syndromes that require advanced and multidisciplinary care.
Oncology
Starting from the in-utero stage of life, a complex regulatory system controls the growth, maturation, proliferation, and death of each cell in the human body. Cancer results from the accumulation of genetic damage in these regulatory mechanisms at the cellular level, leading to the uncontrolled growth of dysfunctional or non-functional cells in a specific part of the body. While cancer may occur in any tissue and organ, and many different types of cancer can arise from the same tissue, all cancers share a common feature: uncontrolled, abnormal cell division.
Rare Diseases
Diseases that affect a small percentage of people compared to the general population are known as rare diseases. Specific problems arise in these disorders due to their rare occurrence. While a disease can be rare in one region, it may be common in another.
To date, more than 7,000 rare diseases have been identified, and this number continues to grow.
Oncology
Starting from the in-utero stage of life, a complex regulatory system controls the growth, maturation, proliferation, and death of each cell in the human body. Cancer results from the accumulation of genetic damage in these regulatory mechanisms at the cellular level, leading to the uncontrolled growth of dysfunctional or non-functional cells in a specific part of the body. While cancer may occur in any tissue and organ, and many different types of cancer can arise from the same tissue, all cancers share a common feature: uncontrolled, abnormal cell division.
Hematology
The hematologic system plays a vital role in oxygen transport, immune defense, coagulation and cellular homeostasis. Disorders affecting this system may arise from defects in blood cell production, proliferation, differentiation or immune regulation. The clinical spectrum ranges from acquired conditions to genetically driven immune dysregulation syndromes that require advanced and multidisciplinary care.
Explore Markets
Inpharmus has an established presence in each of the territories shown on this interactive map.
Click on a region to learn more about our regional operations and the local market opportunities we can help you access.